Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    User Placeholder

    Hi,

    Logout

    India
    Business
    World
    Politics
    Sports
    Technology
    Entertainment
    Auto
    Lifestyle
    Inspirational
    Career
    Bengaluru
    Delhi
    Mumbai

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
    Home / News / India News / Coronavirus vaccine: Bharat Biotech's COVAXIN gets expert panel nod
    Next Article
    Coronavirus vaccine: Bharat Biotech's COVAXIN gets expert panel nod

    Coronavirus vaccine: Bharat Biotech's COVAXIN gets expert panel nod

    By Siddhant Pandey
    Jan 03, 2021
    10:12 am

    What's the story

    A government-appointed panel on Saturday recommended emergency-use authorization (EUA) to the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech.

    The panel submitted its findings to the Drugs Controller General of India (DCGI), who will take a final call on the issuance of EUA.

    Covishield—the vaccine developed by AstraZeneca and Oxford University, and manufactured by Pune-based Serum Institute of India—has also received the panel's nod.

    Panel

    CDSCO panel recommends 'restricted use in emergency situation'

    The Subject Expert Committee (SEC) of Central Drugs Standards Control Organisation (CDSCO) had on Saturday recommended the "grant of permission for restricted use in emergency situation in public interest as an abundant precaution, in clinical trial mode, especially in the context of infection by mutant strains, to M/s Bharat Biotech International Ltd, Hyderabad," the Union Health Ministry said.

    You're
    16%
    through

    Trial data

    Recommendation comes despite lack of efficacy data

    Notably, the panel's recommendation comes despite a lack of trial data indicating the vaccine's efficacy.

    COVAXIN has completed two out of three clinical trials so far. The third trial—which had started in November—tests for vaccine efficacy.

    Bharat Biotech said it has successfully recruited 23,000 out of 26,000 Phase III trial volunteers.

    Phase I and II trials had shown positive safety and immunogenicity results.

    You're
    33%
    through

    Information

    'We have very robust Phase I and II results'

    Dr. Savita Verma—a pharmacology professor from Haryana's PGIMS working on the vaccine—told NDTV, "We have very robust Phase I and II results, in which good efficacy was shown." Dr. Verma also said that around 10 million doses of COVAXIN are ready.

    You're
    50%
    through

    Covishield

    Panel had recommended nod to Covishield on Friday

    Earlier on Friday, the CDSCO panel had recommended Covshield for approval as well.

    The vaccine will "protect 95% of (its) patients," AstraZeneca CEO Pascal Soriot had said last week.

    Serum Institute CEO Adar Poonawalla has said that roughly 50 million doses, most of which will go to India, are already stockpiled.

    India will also be contributing doses to the global COVAX facility.

    You're
    66%
    through

    Information

    Pfizer-BioNTech vaccine also awaiting emergency approval grant

    The vaccine developed by Pfizer and BioNTech, Tozinameran or BNT162b2, is also under review by the CDSCO panel for emergency approval in India. The company is reportedly yet to present its data before the panel. The vaccine has notably been approved in several countries.

    You're
    83%
    through

    Recent news

    India had held dry run for vaccine delivery yesterday

    The government had on Saturday conducted a day-long trial run of the vaccine delivery system to check for potential challenges.

    The exercise was conducted in 116 districts and nearly one lakh personnel had undergone the necessary training, the Health Ministry said.

    Health Minister Dr. Harsh Vardhan said Sunday morning that there should be no misconceptions about vaccines approved in India.

    Done!
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    Latest
    Union Health Ministry
    Central Drugs Standard Control Organization (CDSCO)
    Drugs Controller General of India
    Bharat Biotech

    Latest

    Zee Cine Awards 2025: Kartik, Shraddha bag top honors Ananya Panday
    In India's global diplomatic outreach, who goes where Brazil
    Mexican Navy ship collides with NYC's Brooklyn Bridge New York City
    Trump appoints 2 jihadists to White House advisory board Donald Trump

    Union Health Ministry

    Coronavirus: India's tally crosses 83 lakh; Delhi reports record spike India
    Coronavirus: India's tally crosses 84 lakh; over 1.25 lakh dead India
    Coronavirus: India's tally reaches 85.5 lakh with 46k+ new cases India
    Coronavirus: India's tally nears 86 lakh with 37k new cases India

    Central Drugs Standard Control Organization (CDSCO)

    Bengaluru Lake Frothing: Centre seeks CPCB's response over phosphorus pollution Climate Change
    Health Ministry bans sale of 14 steroid-creams sans doctor's prescription Ministry of Health and Family Welfare
    Government plans to make companies responsible for drug regulation violations India
    Health Ministry to rename drug regulator CDSCO; invites suggestions India

    Drugs Controller General of India

    India may have a vaccine for dengue by 2019-end India
    GSK recalls popular antacid Zinetac amid concerns over cancer-causing substance India
    #GoodNews: Pune's Mylab approved to make COVID-19 test kits India
    Remdesivir reportedly approved for COVID-19 treatment in India COVID-19 Vaccine

    Bharat Biotech

    ICMR, Bharat Biotech teaming up to develop Indian COVID-19 vaccine Indian Council of Medical Research (ICMR)
    India's first COVID-19 vaccine, COVAXIN, cleared for human trials Coronavirus
    India targets to launch first COVID-19 vaccine by August 15 Indian Council of Medical Research (ICMR)
    India's second COVID-19 vaccine cleared for human trials: Details here Drugs Controller General of India
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2025